Related references
Note: Only part of the references are listed.Novel BRCA2 pathogenic variant c.5219 T > G; p.(Leu1740Ter) in a consanguineous Senegalese family with hereditary breast cancer
Jean Pascal Demba Diop et al.
BMC MEDICAL GENETICS (2019)
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations
Timothy R. Rebbeck et al.
HUMAN MUTATION (2018)
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
Karoline B. Kuchenbaecker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Identification of a founder BRCA1 mutation in the Moroccan population
F. Quiles et al.
CLINICAL GENETICS (2016)
Stage at diagnosis of breast cancer in sub-Saharan Africa: a systematic review and meta-analysis
Elima Jedy-Agba et al.
LANCET GLOBAL HEALTH (2016)
Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women
Timothy R. Rebbeck et al.
BREAST CANCER RESEARCH (2016)
The spectrum of BRCA1 and BRCA2 alleles in Latin America and the Caribbean: a clinical perspective
Julie Dutil et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
A Review on Breast Cancer Care in Africa
Eva J. Kantelhardt et al.
BREAST CARE (2015)
Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Peru
J. Abugattas et al.
CLINICAL GENETICS (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Breast cancer in Sub-Saharan Africa: opportunities for prevention
Louise A. Brinton et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
The spectrum of BRCA1 and BRCA2 mutations in breast cancer patients in the Bahamas
M. R. Akbari et al.
CLINICAL GENETICS (2014)
About Sequence Quality: Impact on Clinical Applications
Tetsuro Noguchi et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2014)
Stage at breast cancer diagnosis and distance from diagnostic hospital in a periurban setting: A South African public hospital case series of over 1,000 women
Caroline Dickens et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE
Nasim Mavaddat et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Clinico-pathological features of breast carcinoma in elderly Egyptian patients: A comparison with the non-elderly using population-based data
Ahmed Abdelmabood Zeeneldin et al.
JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE (2013)
Socio-demographic factors and reasons associated with delay in breast cancer presentation: A study in Nigerian women
N. A. Ibrahim et al.
BREAST (2012)
Breast Cancer Prognosis in BRCA1 and BRCA2 Mutation Carriers: An International Prospective Breast Cancer Family Registry Population-Based Cohort Study
Pamela J. Goodwin et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
High Incidence of Triple-Negative Tumors in Sub-Saharan Africa: A Prospective Study of Breast Cancer Characteristics and Risk Factors in Malian Women Seen in a Bamako University Hospital
Madani Ly et al.
ONCOLOGY (2012)
A high prevalence of BRCA1 mutations among breast cancer patients from the Bahamas
Talia Donenberg et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Patient-mediated factors predicting early- and late-stage presentation of breast cancer in Egypt
Jaye M. Stapleton et al.
PSYCHO-ONCOLOGY (2011)
Breast Cancer Profile in a Group of Patients Followed up at the Radiation Therapy Unit of the Yaounde General Hospital, Cameroon
J. D. Kemfang Ngowa et al.
OBSTETRICS AND GYNECOLOGY INTERNATIONAL (2011)
Presymptomatic breast cancer in Egypt: role of BRCA1 and BRCA2 tumor suppressor genes mutations detection
Safinaz S. Ibrahim et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
Evidence for an ancient BRCA1 mutation in breast cancer patients of yoruban ancestry
Bifeng Zhang et al.
FAMILIAL CANCER (2009)
Population Differences in Breast Cancer: Survey in Indigenous African Women Reveals Over-Representation of Triple-Negative Breast Cancer
Dezheng Huo et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions
A. C. Antoniou et al.
BRITISH JOURNAL OF CANCER (2008)
Meta-analysis of BRCA1 and BRCA2 penetrance
Sining Chen et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Factors affecting outcome for young women with early stage invasive breast cancer treated with breast-conserving therapy
Ping Zhou et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Disease-specific and event-free survival in breast cancer patients: a hospital-based study between 1990 and 2001
N. Mallol et al.
REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE (2006)
Survival of young and older breast cancer patients in Geneva from 1990 to 2001
E Rapiti et al.
EUROPEAN JOURNAL OF CANCER (2005)
Kruppel-Like factor 6 (KLF6) is a tumor-suppressor gene frequently inactivated in colorectal cancer
HL Reeves et al.
GASTROENTEROLOGY (2004)
BRCA1 mutations in South African breast and/or ovarian cancer families:: Evidence of a novel founder mutation in Afrikaner families
MD Reeves et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies
A Antoniou et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Breast cancer in adolescents and young women
C Shannon et al.
EUROPEAN JOURNAL OF CANCER (2003)
Founder BRCA 1 and 2 mutations among a consecutive series of Ashkenazi Jewish ovarian cancer patients
DH Tobias et al.
GYNECOLOGIC ONCOLOGY (2000)
Share Paper
